GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Astrazeneca Plc (AZN) [hlAlert]

AstraZeneca PLC (AstraZeneca) is engaged in the discovery, development, manufacturing and marketing of prescription pharmaceuticals and biological products for important areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. The Company?s product
portfolio comprise: Arimidex, Crestor, Nexium, Seroquel and Symbicort. It has operations in various markets, such as China, United Kingdom, Sweden and the United States. It has 26 manufacturing sites in 18 countries. Cardiovascular product pipeline includes Saxagliptin, Dapagliflozin, Atherosclerosis/dyslipidaemia, Thrombosis and Atrial fibrillation. Gastrointestinal pipeline includes life cycle management initiatives. AstraZeneca?s Infection pipeline MedImmune and Dedicated tuberculosis (TB) research. Oncology product pipeline includes Zactima (vandetanib), Zactima (vandetanib), ZD4054 and MedImmune.
.
( Total: 20 Current Stock Recommendations )
Astrazeneca Plc   (20)
Sell 30% Hold 40% Buy 30%
Related companies
Glaxosmithkline Plc   (19)
Sell 16% Hold 63% Buy 21%
Abbott Laboratories   (29)
Sell Hold 24% Buy 69%
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
Alcon Inc   (11)
Hold 64% Buy 36%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Merck & Company, ...   (24)
Hold 25% Buy 75%
Filter by Gains:   
  
Rating:
None
Astrazeneca Plc (AZN) rated Equal Weight by Barclays
Tuesday,  Jan 19, 2016  1:25 PM ET

Rating:
Buy AZN
down 8.74 %
Astrazeneca Plc (AZN) upgraded to Overweight by Morgan Stanley
Tuesday,  Dec 1, 2015  12:25 PM ET

Rating:
Buy AZN
down 6.81 %
Astrazeneca Plc (AZN) rated Buy by Bryan Garnier
Friday,  Sep 18, 2015  10:25 AM ET

Rating:
Sell AZN
up 3.29 %
Astrazeneca Plc (AZN) downgraded to Underweight by JP Morgan
Friday,  Mar 14, 2014  8:25 AM ET

Rating:
Sell AZN
up 5.82 %

Rating:
Buy AZN
up 1.68 %

Rating:
Buy AZN
up 1.68 %
Astrazeneca Plc (AZN) rated Outperform by Leerink Swann
Tuesday,  Jan 14, 2014  8:25 AM ET

Rating:
Hold AZN
down 14.85 %
Astrazeneca Plc (AZN) upgraded to Hold by Jefferies
Thursday,  Jan 9, 2014  11:25 AM ET

Rating:
Hold AZN
Astrazeneca Plc (AZN) upgraded to Neutral by BofA/Merrill
Monday,  Oct 28, 2013  8:25 AM ET

Rating:
Sell AZN
down 14.85 %
Astrazeneca Plc (AZN) downgraded to Underperform by Jefferies
Friday,  Oct 11, 2013  8:25 AM ET

Rating:
Hold AZN
Astrazeneca Plc (AZN) upgraded to Neutral by JP Morgan
Tuesday,  Apr 2, 2013  8:25 AM ET

Rating:
Hold AZN
Astrazeneca Plc (AZN) rated Neutral by Natixis Bleichroeder
Friday,  Mar 22, 2013  9:25 AM ET

Rating:
Sell AZN
down 25.73 %
Astrazeneca Plc (AZN) rated Sell by Societe Generale
Friday,  Dec 14, 2012  8:25 AM ET

Rating:
Hold AZN
Astrazeneca Plc (AZN) rated Neutral by Exane BNP Paribas
Wednesday,  Sep 19, 2012  8:25 AM ET

Rating:
Sell AZN
down 12.37 %
Astrazeneca Plc (AZN) rated Underperform by BofA/Merrill
Monday,  Sep 10, 2012  8:25 AM ET

Your Recent Stocks
SymbolLastChange
AZN 28.49 down  -9.87 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy